News
In the wake of this sell-off, a critical question arises about whether LLY stock represents a buying opportunity.
The Dow and S&P 500 eased on Thursday, as shares of Eli Lilly dropped after data from its oral weight loss drug disappointed, ...
22hon MSN
The stock is struggling badly, and if things don't improve in short order, Eli Lilly will be on track for its worst ...
Eli Lilly on Thursday released data for its daily obesity pill, orforglipron, which found the medication helped obese or ...
The iPhone maker's shares [rallied for a second day]( ...
Eli Lilly (LLY) has recently launched SenderraCare+, a digital solution paired with its biologic treatment EBGLYSS, and announced positive outcomes from a Phase 3 trial for the weight management drug ...
Eli Lilly stock falls 14% after new obesity drug underwhelms in clinical trial. Analysts maintain Buy rating, citing strong ...
1don MSN
Complaints pour in over Army Corps’ Los Angeles fire cleanup efforts Helicopter crashes into barge on Mississippi River near ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results